BioPharmaceutical Business Intelligence
- Identify first generic entrants
- Uncover prior art in expired and abandoned patents
- Drug patents in 130+ countries
► See Plans & Pricing
Serving 500+ biopharmaceutical companies globally:
Reach a Targeted Audience
The free Patent Expiration Bulletin is your vehicle to reach a
targeted pharmaceutical industry audience. Subscribers include:
- Big pharma
- Domestic and international generic firms
- Healthcare payers
- Federal and state government agencies
- Distributors, wholesalers, and pharmacies
- Lawyers and consultants
The bulletin is sent to more than 22,000 targeted opt-in readers every month.
It is your opportunity to reach
your audience by permission marketing; direct to their inboxes.
Reach 22,000+ readers
Send your rich-text HTML message to the entire list.
Top placement in the weekly drug patent expiration newsletter.
Related Products from thinkBiotech